Assessing the Impact on Quality of Life: Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir for Hepatitis C Patients

The interplay between innovative drug regimens and patients' health-related quality of life (HRQL) is a critical area of focus in Clinical Outcomes Research. The ultimate goal of any treatment is not just clinical recovery but also improving the overall quality of life of the patient. With this approach, we conduct our research and studies at Clinical Outcomes Solutions (COS).


Stacie Hudgens’ Insightful Contribution

We are pleased to announce the publication of an article by Stacie Hudgens, our esteemed Chief Executive Officer and Strategic Lead for Regulatory and Access, in the renowned Liver International journal. Her article titled 'Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis C' delves deep into the impact of this specific drug regimen on the HRQL of Hepatitis C patients.

Hepatitis C, a disease affecting millions worldwide, poses physical challenges and can profoundly impact a patient's quality of life. The article explores how the mentioned drug regimen affects patients' lives beyond clinical parameters. Such research is vital in ensuring that new treatments offer comprehensive benefits to patients, enhancing their well-being and overall life satisfaction.


Pushing the Boundaries of Clinical Outcomes Research

This article exemplifies COS's dedication to understanding the holistic effects of treatments on patients. It is not enough for a treatment to be clinically effective; it must also contribute positively to a patient's quality of life. Stacie Hudgens' research in this domain further solidifies COS's leadership in patient-centric clinical outcomes research.

For professionals, researchers, and stakeholders who wish to gain deeper insights into this study, we invite you to read the full article in Liver International.


A Continued Commitment to Excellence

As we celebrate this contribution, our dedication to furthering the cause of patient-centered research remains stronger than ever. We believe that every study every piece of research, brings us one step closer to improving patient care holistically.

Join us as we continue to explore, study, and strive for excellence, ensuring that treatments heal and enhance the quality of life.

Stay connected for more updates, insights, and groundbreaking contributions from the world of Clinical Outcomes Research.

Previous
Previous

Diving Deep into the Quality of Life: Ovarian Maintenance Clinical Trials Analyzed

Next
Next

Spotlight on Clinical Outcomes Research: Presentations at the Joint Statistical Meeting 2018